Parents with children in sports often worry about concussions. It's an anxiety that one western Wisconsin company is trying to allay with technology.
The EyeBox, developed and sold by New Richmond, Wis.-based Oculogica Inc., can help diagnose a possible concussion in less than four minutes — 220 seconds, to be precise.
Rather than trusting a patient's self-reported symptoms, the EyeBox tracks eye movement to tell the truth about the current condition of the patient's brain.
The latest version of EyeBox secured FDA clearance in January and is now being launched. On Tuesday, St. Paul-based Minnetronix Medical announced it had been selected to manufacture Oculogica's device.
The noninvasive, battery-operated machine uses an algorithm and machine learning to assess "cranial nerve function through eye-tracking abnormalities and micro-eye movements."
"We're selling our first ones; we've got a small waiting list," said Rosina Samadani, CEO of Oculogica.
Her sister, Uzma Samadani, founded the company in 2013 when she was based in New York. Uzma Samadani is a Twin Cities neurosurgeon and associate professor at the University of Minnesota.
The EyeBox received its first FDA clearance in December 2018; the latest is the company's fourth clearance. It is the first, and so far only, device of its type to secure FDA clearance.